Tag: John Bonfiglio
January 10, 2017
TapImmune Launches Phase 2 Ovarian Cancer Trial In Platinum-Sensitive Patients
TapImmune, Inc. (NASDAQ: TPIV), a clinical-stage immuno-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for...
January 3, 2017
Top Biotech Trends for 2017
No doubt about it—2016 was a tumultuous year for biotech. But that doesn’t mean you should be afraid of this...
December 6, 2016